Floatz logo

5-FLUOROCYTOSINE

Neoplasms

Anaeropharma Science, Inc.Small moleculePhase 1/2Dormant
C
36/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
27/ 100
Competitive Position
65/ 100

Competitive context

119 Active assets in the Neoplasms cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Hellenic Society of Hematology
Phase 3BB
Feladilimab
GlaxoSmithKline
Phase 2BB
Carboplatin
Bristol-Myers Squibb
Phase 3BB
PREDNISONE TABLETS
The First Affiliated Hospital of Soochow University
Phase 3B
Letrozole
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 2B

View all 50 →

Same molecule, other indications

5-FLUOROCYTOSINE is also rated in:

glioblastomaDormant
CCC
Indicative ·
54 / 100
View asset →
anaplastic astrocytomaDormant
CCC
Indicative ·
52 / 100
View asset →
anaplastic oligodendrogliomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →